Control of endothelial cell function and arteriogenesis by MEG3:EZH2 epigenetic regulation of integrin expression.
ChIRP
EZH2
MEG3
MT: RNA and epigenetic editing Special Issue
PRC2
RNA binding
arteriogenesis
endothelial cells
limb ischemia
lncRNA
polycomb
Journal
Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621
Informations de publication
Date de publication:
11 Jun 2024
11 Jun 2024
Historique:
received:
15
11
2022
accepted:
14
03
2024
medline:
15
4
2024
pubmed:
15
4
2024
entrez:
15
4
2024
Statut:
epublish
Résumé
Epigenetic processes involving long non-coding RNAs regulate endothelial gene expression. However, the underlying regulatory mechanisms causing endothelial dysfunction remain to be elucidated. Enhancer of zeste homolog 2 (EZH2) is an important rheostat of histone H3K27 trimethylation (H3K27me3) that represses endothelial targets, but EZH2 RNA binding capacity and EZH2:RNA functional interactions have not been explored in post-ischemic angiogenesis. We used formaldehyde/UV-assisted crosslinking ligation and sequencing of hybrids and identified a new role for maternally expressed gene 3 (MEG3). MEG3 formed the predominant RNA:RNA hybrid structures in endothelial cells. Moreover, MEG3:EZH2 assists recruitment onto chromatin. By EZH2-chromatin immunoprecipitation, following MEG3 depletion, we demonstrated that MEG3 controls recruitment of EZH2/H3K27me3 onto integrin subunit alpha4 (
Identifiants
pubmed: 38617973
doi: 10.1016/j.omtn.2024.102173
pii: S2162-2531(24)00060-X
pmc: PMC11015509
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102173Informations de copyright
© 2024.
Déclaration de conflit d'intérêts
The authors declare no competing interests.